<SEC-DOCUMENT>0001104659-25-044363.txt : 20250505
<SEC-HEADER>0001104659-25-044363.hdr.sgml : 20250505
<ACCEPTANCE-DATETIME>20250505080048
ACCESSION NUMBER:		0001104659-25-044363
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250502
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250505
DATE AS OF CHANGE:		20250505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMN HEALTHCARE SERVICES INC
		CENTRAL INDEX KEY:			0001142750
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HELP SUPPLY SERVICES [7363]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				061500476
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16753
		FILM NUMBER:		25910963

	BUSINESS ADDRESS:	
		STREET 1:		2999 OLYMPUS BOULEVARD
		STREET 2:		SUITE 500
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75019
		BUSINESS PHONE:		8668718519

	MAIL ADDRESS:	
		STREET 1:		2999 OLYMPUS BOULEVARD
		STREET 2:		SUITE 500
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75019
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2513592d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:AMN="http://amnhealthcare.com/20250502">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_AMN_amnhealthcare.com_20250502 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20250502_20250502 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001142750 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001142750</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="amn-20250502.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-02</xbrli:startDate>
        <xbrli:endDate>2025-05-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
WASHINGTON, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_90B_edei--DocumentType_c20250502__20250502_zJwGiSbSuJDk"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT<br/>
PURSUANT TO SECTION&#160;13 OR 15(D)&#160;OF<br/>
THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of report (Date of earliest event reported):
<span id="xdx_908_edei--DocumentPeriodEndDate_c20250502__20250502_z0zNoJ8iEjti"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 2, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font-size: 14pt; text-align: center; margin-top: 0; margin-bottom: 0"><b><span id="xdx_909_edei--EntityRegistrantName_c20250502__20250502_zFTFV47PEkx3"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000011" name="dei:EntityRegistrantName">AMN HEALTHCARE SERVICES,&#160;INC.</ix:nonNumeric></span></b></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0">(Exact name of registrant as specified in its charter)</p>



<p style="margin: 0; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20250502__20250502_z0fyCLR5b4k2"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 34%; text-align: center"><b><span id="xdx_90D_edei--EntityFileNumber_c20250502__20250502_zPqgWaJGRjT5"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000013" name="dei:EntityFileNumber">001-16753</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 33%"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20250502__20250502_zAPqeQ80LUB4"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">06-1500476</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or other jurisdiction <br/>
of incorporation)</td>
    <td style="text-align: center">(Commission <br/>
File Number)</td>
    <td style="text-align: center">(I.R.S. Employer <br/>
Identification No.)</td></tr>
</table>

<p style="margin: 0; font-size: 10pt">&#160;</p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20250502__20250502_zld0jCU1XYB9"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000015" name="dei:EntityAddressAddressLine1">2999 Olympus
Boulevard</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20250502__20250502_ztPj3W1ZP94b"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 500</ix:nonNumeric></span><br/> <span id="xdx_90B_edei--EntityAddressCityOrTown_c20250502__20250502_zpklyn7d2M17"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000017" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20250502__20250502_zPNsPH16RCQ4"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20250502__20250502_zSr2EgzIkNyh"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000019" name="dei:EntityAddressPostalZipCode">75019</ix:nonNumeric></span></b><br/> (Address of principal executive offices) (Zip Code) &#160;</span></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>(<span id="xdx_905_edei--CityAreaCode_c20250502__20250502_zcmzjKei9pEk"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000020" name="dei:CityAreaCode">866</ix:nonNumeric></span>) <span id="xdx_908_edei--LocalPhoneNumber_c20250502__20250502_zoAmxOXNTJp1"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000021" name="dei:LocalPhoneNumber">871-8519</ix:nonNumeric></span></b></span></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b></b> (Registrant&#8217;s Telephone Number,&#160;Including Area Code) &#160;</span></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>Not
Applicable</b></span></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b></b> (Former Name or Former Address, if Changed Since Last Report)</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i>
General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.5in"><span style="font-family: Wingdings"><span id="xdx_90C_edei--WrittenCommunications_c20250502__20250502_zRkE81DKinP3"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Wingdings"><span id="xdx_903_edei--SolicitingMaterial_c20250502__20250502_z1R2OPHI8mv4"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20250502__20250502_zlitoH4OWsQ6"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20250502__20250502_zHsifR9PFoC"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 32%">Title of each class</td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 32%">Trading Symbol(s)</td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 32%">Name of each exchange <br/>
on which registered</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_908_edei--Security12bTitle_c20250502__20250502_z8HmpAKtKHtc"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_907_edei--TradingSymbol_c20250502__20250502_z1FfD4IIRzul"><ix:nonNumeric contextRef="AsOf2025-05-02" id="Fact000027" name="dei:TradingSymbol">AMN</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20250502__20250502_zwawNhVvszlc"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2 of the
Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Emerging growth company&#8239;<span style="font-family: Wingdings"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20250502__20250502_zzemLWwwdN6k"><ix:nonNumeric contextRef="AsOf2025-05-02" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section&#160;13(a)&#160;of the Exchange Act.&#8239;<span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 5.02.</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors of AMN Healthcare Services,&#160;Inc. (the &#8220;Company&#8221;)
previously approved, subject to shareholder approval, the AMN Healthcare 2025 Equity Plan (the &#8220;Plan&#8221;). The Company&#8217;s
shareholders approved the Plan at the Annual Meeting of Shareholders of the Company held on May&#160;2, 2025 (the &#8220;Annual Meeting&#8221;).
A description of the material terms of the Plan is included in the Company&#8217;s Definitive Proxy Statement on Schedule 14A for the
Annual Meeting, filed with the Securities and Exchange Commission on March&#160;18, 2025 (the &#8220;Proxy Statement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The description of the Plan is qualified in its entirety by reference
to the full text of the Plan, which is filed as Exhibit&#160;10.1 hereto, and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 5.07.</b></td><td><b>Submission of Matters to a Vote of Security Holders.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the Annual Meeting held on May&#160;2, 2025, the Company&#8217;s
shareholders voted on five proposals as set forth below, each of which is described in greater detail in the Proxy Statement. The number
of votes cast for and against, and the number of abstentions and broker non-votes, with respect to each matter voted upon are set forth
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">1.</td><td>The individuals listed below were elected at the Annual Meeting by the vote set forth in the table immediately below to serve as directors
of the Company until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 23%; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jorge A. Caballero</span></td>
    <td style="width: 3%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,632,488</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,144</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,569</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark G. Foletta</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,748,788</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,052,686</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,727</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Teri G. Fontenot</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,643,973</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">157,810</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,418</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cary S. Grace</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,642,724</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,073</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,404</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R. Jeffrey Harris</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,856,648</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">944,645</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,908</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James H. Hinton</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,547,316</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,994</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,891</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celia P. Huber</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,646,495</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155,576</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,130</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daphne E. Jones</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,638,757</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">161,462</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,982</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sylvia D. Trent-Adams</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,378,054</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">423,594</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,553</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">2.</td><td>The approval, on an advisory basis, of the compensation paid to the Company&#8217;s named executive officers, as described in the
Proxy Statement. This proposal was approved as set forth immediately below:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,059,546</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,703,892</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,763</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>





<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">3.</td><td>The ratification of the appointment of KPMG LLP as the Company&#8217;s independent registered public accounting firm for the fiscal
year ending December&#160;31, 2025. This proposal was approved as set forth immediately below:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,606,644</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">656,046</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,575</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">4.</td><td>The approval of the AMN Healthcare 2025 Equity Plan. This proposal was approved as set forth immediately below:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,953,916</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">849,838</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,447</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">5.</td><td>The shareholder proposal entitled &#8220;Special Shareholder Meeting Improvement.&#8221; This proposal was not approved as set forth
immediately below:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker Non-Votes</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,976,787</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,818,286</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,128</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,460,064</span></td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 9.01.</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 1in"><b>Exhibit&#160;No.</b></td>
    <td style="width: 0.2in">&#160;</td>
    <td style="border-bottom: Black 1pt solid"><b>Description</b></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2513592d1_ex10-1.htm">10.1</a></td>
    <td>&#160;</td>
    <td><a href="tm2513592d1_ex10-1.htm">AMN Healthcare 2025 Equity Plan.</a></td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>&#160;</td>
    <td>Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>AMN Healthcare Services,&#160;Inc.</b></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>Date: May&#160;5, 2025</td>
    <td>By:</td>
    <td style="border-bottom: black 1pt solid">/s/ Cary Grace</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name:</td>
    <td>Cary Grace</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title: </td>
    <td><i>Chief Executive Officer</i></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PbTWn4vd6ZgiTpEh4m11UYpbM9L690i+pXVDDIGQnPPlCBGLBc1NhQyHWZHDDuum0h6hwDMy2hMGR7pcJRBmgRfjPGvr2/UHphQYDMykJ4/h3jrvxmGZgBz1h7KvxiBVooYwXYvoq6dkz6ZE642uQNsStkwNG/SaX92HnX6SpfrVJu2RnSGbwKAnO/kNSg4UbOiuH8RXB3meiihuKxILplsTXNnTo/2SkFVYhzjX0f+OPr6ISkY= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2513592d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-right: 0; margin-bottom: 0"><B>Exhibit&nbsp;10.1</B></P>

<P STYLE="text-align: justify; margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>AMN
Healthcare 2025 Equity Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;1. <I>GENERAL
PURPOSE OF THE PLAN; DEFINITIONS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The name of the plan
is the AMN Healthcare 2025 Equity Plan (as may be amended from time to time, the &ldquo;<B><I><U>Plan</U></I></B>&rdquo;). The purpose
of the Plan is to encourage and enable the officers, employees, directors, and other key persons (including consultants and prospective
employees) of AMN Healthcare Services,&nbsp;Inc., a Delaware corporation (the &ldquo;<B><I><U>Company</U></I></B>&rdquo;), and its Subsidiaries
upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business to acquire a proprietary
interest in the Company. It is anticipated that providing such persons with a direct stake in the Company&rsquo;s welfare will assure
a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company&rsquo;s
behalf and strengthening their desire to remain with the Company. The following terms shall be defined as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>409A
Award</U></B>&rdquo; </I>is defined in Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Administrator</U></B>&rdquo;
</I>is defined in Section&nbsp;2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Award</U></B>&rdquo;
</I>or <I>&ldquo;<B><U>Awards</U></B>,&rdquo; </I>except where referring to a particular category of grant under the Plan, shall include
Incentive Stock Options, Non-Qualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Unit Awards
and Unrestricted Stock Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Board</U></B>&rdquo;
</I>means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Code</U></B>&rdquo;
</I>means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations, and interpretations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Committee</U></B>&rdquo;
</I>means the compensation committee of the Board or a similar committee performing the functions of the compensation committee and that
is comprised of (unless the Board determines otherwise) not less than two Non-Employee Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Company</U></B>&rdquo; </I>is
defined in the introductory paragraph of this Section&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Company&rsquo;s Previous
Equity Plan</U></B>&rdquo; </I>means the AMN Healthcare 2017 Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Exchange Act</U></B>&rdquo;
</I>means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Fair
Market Value</U></B>&rdquo; </I>of the Stock on a given date, unless otherwise determined by the Administrator, means (i)&nbsp;if the
Stock is listed or admitted to trading on any stock exchange, the closing price as reported by such stock exchange (for example, on its
official web site, such as www.nyse.com), (a)&nbsp;for the purpose of determining the tax withholding due upon the vesting or settlement
of Restricted Stock Awards, Restricted Stock Unit Awards and Unrestricted Stock Awards and the related purpose of valuing Stock withheld
from such Awards to satisfy tax withholding obligations, on the business day prior to such date, (b)&nbsp;for all other purposes under
the Plan, on such date, or, (c)&nbsp;if there is no trading of Stock on the applicable date set forth in clause (i)(a)&nbsp;or (i)(b),
such closing price on the next preceding date on which there was trading in such Stock; (ii)&nbsp;if the Stock is not listed or admitted
to trading on a stock exchange, the mean between the lowest reported bid price and highest reported ask price of the Stock in the over-the-counter
market, as reported by such over-the-counter market (for example, on its official web site, such as www.otcbb.com), (a)&nbsp;for the purpose
of determining the tax withholding due upon the vesting or settlement of Restricted Stock Awards, Restricted Stock Unit Awards and Unrestricted
Stock Awards and the related purpose of valuing Stock withheld from such Awards to satisfy tax withholding obligations, on the business
day prior to such date, (b)&nbsp;for all other purposes under the Plan, on such date, (c)&nbsp;if there is no trading of Stock on the
applicable date set forth in clause (ii)(a)&nbsp;or (ii)(b), such mean on the next preceding date on which there was a report, or (d)&nbsp;if
no official report exists, as reported on the applicable date by any publication of general circulation selected by the Company that regularly
reports the market price of the shares of Stock in such market; or (iii)&nbsp;if the Stock is neither listed on an established securities
exchange, national market system or automated quotation system nor regularly quoted by a recognized securities dealer, its Fair Market
Value shall be established by the Committee with respect to such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Incentive
Stock Option</U></B>&rdquo; </I>means any Stock Option designated and qualified as an &ldquo;incentive stock option&rdquo; as defined
in Section&nbsp;422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Non-Employee
Director</U></B>&rdquo; </I>means a member of the Board who qualifies as a &ldquo;Non-Employee Director&rdquo; as defined in Rule&nbsp;16(b)-3
promulgated under the Exchange Act or any successor definition thereof adopted by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Non-Qualified Stock Option</U></B>&rdquo;
</I>means any Stock Option that is not an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Option</U></B>&rdquo; </I>or
<I>&ldquo;<B><U>Stock Option</U></B>&rdquo; </I>means any option to purchase shares of Stock granted pursuant to Section&nbsp;5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Option Award</U></B>&rdquo;
</I>or <I>&ldquo;<B><U>Stock Option Award</U></B>&rdquo; </I>means any Award granted pursuant to Section&nbsp;5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&ldquo;<B><I><U>Parent</U></I></B>&rdquo;
means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations
other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations
in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent
commencing as of such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Performance
Criteria</U></B>&rdquo; </I>used in performance goals governing performance-based Awards may include without limitation:
(i)&nbsp;market value; (ii)&nbsp;book value; (iii)&nbsp;earnings or earnings per share (either basic or diluted), in each case,
either before or after taxes (and other adjustments, including, without limitation, adjustments for stock compensation expense,
integration expenses, incentive awards recorded in the Company&rsquo;s financial books and records, including annual and long-term
incentive awards, extraordinary legal costs (including damages, settlements and attorneys&rsquo; fees), changes in United States
Generally Accepted Accounting Principles (&ldquo;<B><I><U>GAAP</U></I></B><I>&rdquo;<B>) </B></I>treatment of revenue or expenses,
discontinued operations, goodwill and other identified asset impairments, depreciation and amortization, and expenses resulting from
severance arrangements with terminated employees); (iv)&nbsp;market share; (v)&nbsp;operating profit; (vi)&nbsp;net income;
(vii)&nbsp;cash flow; (viii)&nbsp;return on capital or invested capital; (ix)&nbsp;return on assets; (x)&nbsp;return on equity;
(xi)&nbsp;margins; (xii)&nbsp;total shareholder return; (xiii)&nbsp;sales or product volume growth; (xiv)&nbsp;productivity
improvement or ratios; (xv)&nbsp;costs or expenses; (xvi)&nbsp;net debt reduction; (xvii)&nbsp;earnings before interest, taxes,
depreciation and amortization (and other adjustments, including, without limitation, stock compensation expense, integration
expenses, incentive awards recorded in the Company&rsquo;s financial books and records, including annual and long-term incentive
awards, extraordinary legal costs (including damages, settlements and attorneys&rsquo; fees), changes in GAAP treatment of revenue
or expenses, discontinued operations, goodwill and other identified asset impairments, and expenses resulting from severance
arrangements with terminated employees); (xviii)&nbsp;unit volume; (xix)&nbsp;net sales; (xx)&nbsp;balance sheet measurements;
(xxi)&nbsp;selling, general and administrative expenses (including, without limitation, SG&amp;A as a percentage of revenue or
similar ratios); (xxii)&nbsp;revenue; (xxiii)&nbsp;the Company&rsquo;s Stock price or its enterprise value; (xxiv)&nbsp;completion
of acquisitions or business expansion; (xxv)&nbsp;operating income or (xxvi)&nbsp;any other objective or subjective performance
measure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Performance
Criteria may be measured in absolute terms or as compared to the results of a peer group, other group of comparable companies
selected by the Committee, or an index and may include or exclude, as applicable, the effects of the following events that occur
during a performance period: (a)&nbsp;gains or losses on sales or dispositions, (b)&nbsp;asset write-downs, which may include
without limitation goodwill and other identified intangible asset impairments, (c)&nbsp;changes in tax law or rate, including the
impact on deferred tax liabilities, (d)&nbsp;the cumulative effect of changes in accounting principles or changes in accounting
policies, including changes in GAAP treatment of revenue and expenses, (e)&nbsp;events of an &ldquo;unusual nature&rdquo; and/or of
a type that indicate &ldquo;infrequency of occurrence,&rdquo; as defined in FASB Accounting Standards Update 2015-01,
(f)&nbsp;acquisitions occurring after the start of a performance period, integration expenses related to acquisitions, or unbudgeted
costs incurred related to future acquisitions, (g)&nbsp;operations discontinued, divested or restructured, including severance
costs, (h)&nbsp;gains or losses on refinancing or extinguishment of debt, (i)&nbsp;foreign exchange gains and losses, (j)&nbsp;all
or any portion of litigation expenses (including attorneys&rsquo; fees, court costs and other out-of-pocket expenses), amounts paid
as damages, claim judgments, or settlements, (k)&nbsp;stock compensation expense, (l)&nbsp;expenses resulting from severance
arrangements with terminated employees, (m)&nbsp;incentive awards recorded in the Company&rsquo;s financial books and records,
including annual and long-term incentive awards, (n)&nbsp;depreciation and amortization and (o)&nbsp;any other event or condition
specified in such Award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Plan</U></B>&rdquo; </I>is
defined in the introductory paragraph of this Section&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Restricted Stock</U></B>&rdquo;
</I>is defined in Section&nbsp;7(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Restricted Stock Award</U></B>&rdquo;
</I>means any Award granted pursuant to Section&nbsp;7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Restricted Stock Unit Award</U></B>&rdquo; </I>means any Award
granted pursuant to Section&nbsp;8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Sale Agreement</U></B>&rdquo; </I>is defined in Section&nbsp;3(g)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><I>&ldquo;<U>Sale Event</U>&rdquo; </I></B>means
the consummation of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-align: justify"> (a)&#8239;&#8239;&#8239; the acquisition by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3)&nbsp;or 14(d)(2)&nbsp;of the Exchange Act) other than the Company, any of its Subsidiaries, an employee benefit plan maintained by the Company or a &ldquo;person&rdquo; who, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company (a &ldquo;Person&rdquo;) of beneficial ownership (within the meaning of Rule&nbsp;13d-3 promulgated under the Exchange Act) of a majority of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors;</P>

<P STYLE="margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-align: justify">(b)&#8239;&#8239;&#8239; the sale of all or substantially all of the business or assets of the Company; or</P>

<P STYLE="margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239; the consummation of a merger, consolidation or similar form of corporate transaction involving the Company that requires the approval of the Company&rsquo;s stockholders, whether for such transaction or the issuance of securities in the transaction (a &ldquo;Business Combination&rdquo;), if immediately following such Business Combination:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.75in"><FONT STYLE="font-size: 10pt">(x)&#8239;&#8239;&#8239;&#8239;a Person is or becomes the beneficial owner,
directly or indirectly, of a majority of the combined voting power of the outstanding voting securities eligible to elect directors of
the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation), or</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.75in"> <FONT STYLE="font-size: 10pt">(y)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">the Company&rsquo;s stockholders immediately prior to the Business Combination thereafter cease to beneficially own, directly or indirectly, a majority of the combined voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation in substantially the same proportions as their ownership of the Company immediately prior to the Business Combination (or, if there is no Parent Corporation, the Surviving Corporation). &ldquo;Surviving Corporation&rdquo; shall mean the corporation resulting from a Business Combination, and &ldquo;Parent Corporation&rdquo; shall mean the ultimate parent corporation that directly or indirectly has beneficial ownership of a majority of the combined voting power of the then outstanding voting securities of the Surviving Corporation entitled to vote generally in the election of directors.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Notwithstanding anything
to the contrary, for any Award subject to Section&nbsp;409A, no Sale Event shall be deemed to have occurred for purposes of establishing
a time of payment unless such event constitutes an event specified in Section&nbsp;409A(a)(2)(A)(v)&nbsp;of the Code and the Treasury
regulations promulgated thereunder, provided, that such qualification shall not apply for purposes of determining whether a grantee&rsquo;s
rights to the Award become vested or otherwise unconditional on the Sale Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Section&nbsp;409A</U></B>&rdquo;
</I>means Section&nbsp;409A of the Code and the regulations and other guidance promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Stock</U></B>&rdquo;
</I>means the Company&rsquo;s common stock, par value $.01 per share, subject to adjustments pursuant to Section&nbsp;3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><I>&ldquo;<B><U>Stock
Appreciation Right</U></B>&rdquo; </I>means any Award granted pursuant to Section&nbsp;6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Subsidiary</U></B>&rdquo;
</I>means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations
other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes
of stock in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary on a date after the adoption
of the Plan shall be considered a Subsidiary commencing as of such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Substitute
Award</U></B>&rdquo; </I>means any Award granted pursuant to Section&nbsp;3(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Ten
Percent Owner</U></B>&rdquo; </I>means an employee who owns or is deemed to own (by reason of the attribution rules&nbsp;of Section&nbsp;424(d)&nbsp;of
the Code) more than 10 percent of the combined voting power of all classes of stock of the Company or any Parent or subsidiary corporation
within the meaning of Section&nbsp;424(f)&nbsp;of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><I>&ldquo;<B><U>Unrestricted
Stock Award</U></B>&rdquo; </I>means any Award granted pursuant to Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;2. <I>ADMINISTRATION
OF PLAN; ADMINISTRATOR AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS</I></B></P>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I>Committee</I>. The Plan shall be administered by either the Board or the Committee
(the &ldquo;<B><I><U>Administrator</U></I></B>&rdquo;). The Board shall have discretion to determine whether or not it intends the Plan
(and actions thereunder) to comply with the exemption requirements of Rule&nbsp;16b-3 promulgated under the Exchange Act. However, if
the Board intends to satisfy such exemption requirements, with respect to any grantee subject to Section&nbsp;16 of the Exchange Act,
the Committee, as applicable, shall be a compensation committee of the Board that at all times consists solely of two or more Non-Employee
Directors.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;Powers of Administrator</I>. The Administrator shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-align: justify"> (i) &#8239;&#8239;&#8239;&#8239;to select the individuals to whom Awards may from time to time be granted;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(ii)</FONT> <FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;to determine the time or times of grant, and the extent, if any, of Incentive Stock Options, Non-Qualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Unit Awards and Unrestricted Stock Awards, or any combination of the foregoing, granted to any one or more grantees;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (iii)&#8239;&#8239; to determine the number of shares of Stock to be covered by any Award;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(iv)</FONT> <FONT STYLE="font-size: 10pt">&#8239;&#8239;to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the form of written instruments evidencing the Awards;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (v) &#8239;&#8239;&#8239;to accelerate at any time the exercisability or vesting of all or any portion of any Award, including in the event of death or disability;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (vi) &#8239;&#8239;subject to the provisions of Section&nbsp;5(c), to extend at any time the period in which Stock Options may be exercised; and</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(vii)</FONT> <FONT STYLE="font-size: 10pt">&#8239;at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including related written instruments); to make all determinations it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and to otherwise supervise the administration of the Plan.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">All decisions and interpretations
of the Administrator shall be binding on all persons, including the Company and Plan grantees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;<I>Delegation of Authority to Grant Awards</I>. The Administrator, in its discretion,
may delegate to the Chief Executive Officer of the Company all or part of the Administrator&rsquo;s authority and duties with respect
to the granting of Awards to individuals who are not subject to the reporting and other provisions of Section&nbsp;16 of the Exchange
Act. Any such delegation by the Administrator shall include a limitation as to the amount of Awards that may be granted during the period
of the delegation and shall contain guidelines as to the material terms and conditions of the Awards that are consistent with the terms
of this Plan. The Administrator may revoke or amend the terms of a delegation at any time but such action shall not invalidate any prior
actions of the Administrator&rsquo;s delegate that were consistent with the terms of the Plan.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;<I>Indemnification</I>. Neither the Board nor the Committee, nor any member of
either or any delegate thereof, shall be liable for any act, omission, interpretation, construction, or determination made in good faith
in connection with the Plan, and the members of the Board and the Committee (and any delegate thereof) shall be entitled in all cases
to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation,
reasonable attorneys&rsquo; fees) arising or resulting therefrom to the fullest extent permitted by law and/or under any directors&rsquo;
and officers&rsquo; liability insurance coverage that may be in effect from time to time and/or any indemnification agreement between
such individual and the Company.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;3. <I>STOCK
ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I>Stock Issuable</I>. Subject to adjustment as provided in this Section&nbsp;3,
a total of 1,781,073 shares of Stock shall be authorized for Awards granted under the Plan less one (1)&nbsp;share for every one (1)&nbsp;share
granted under the Company&rsquo;s Previous Equity Plan after March&nbsp;4, 2025. Subject to adjustment as provided in this Section&nbsp;3,
no more than 1,000,000 shares of Stock in the aggregate may be issued under the Plan in connection with Incentive Stock Options. After
stockholder approval of this Plan, no awards may be granted under the Company&rsquo;s Previous Equity Plan.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Add-Back of Certain Shares</I>. If (i)&nbsp;any shares of Stock subject to an Award are forfeited, an Award expires or otherwise terminates without issuance of shares of Stock, or an Award is settled for cash (in whole or in part) or otherwise does not result in the issuance of all or a portion of the shares of Stock subject to such Award (including on payment in shares of Stock on exercise of a Stock Appreciation Right), such shares of Stock shall, to the extent of such forfeiture, expiration, termination, cash settlement or non-issuance, be added to the shares of Stock available for grant under the Plan or (ii)&nbsp;after March&nbsp;4, 2025 any shares of Stock subject to an award under the Company&rsquo;s Previous Equity Plan are forfeited, an award under the Company&rsquo;s Previous Equity Plan expires or otherwise terminates without issuance of such shares of Stock, or an award under the Company&rsquo;s Previous Equity Plan is settled for cash (in whole or in part), or otherwise does not result in the issuance of all or a portion of the shares of Stock subject to such award (including on payment in shares of Stock on exercise of a stock appreciation right), then in each such case the shares of Stock subject to the Award or award under the Previous Equity Plan shall, to the extent of such forfeiture, expiration, termination, cash settlement or non-issuance, be added to the shares of Stock available for grant under the Plan on a one-for-one basis.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">In the event that withholding
tax liabilities arising from a Full-Value Award are satisfied by the tendering of shares of Stock (either actually or by attestation)
or by the withholding of shares of Stock by the Company, then, in each such case, the shares of Stock so tendered or withheld shall be
added to the shares of Stock available for grant under the Plan on a one-for-one basis. In the event that after March&nbsp;4, 2025 withholding
tax liabilities arising from a full-value award under the Previous Equity Plan are satisfied by the tendering of shares of Stock (either
actually or by attestation) or by the withholding of shares of Stock by the Company, then in each such case the shares of Stock so tendered
or withheld shall be added to the shares of Stock available for grant under the Plan on a one-for-one basis. A &ldquo;Full Value Award&rdquo;
means an Award that is neither a Stock Option nor a Stock Appreciation Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>No Recycling of Options or SARs</I>. Notwithstanding anything to the contrary contained herein, the following shares of Stock shall not be added to the shares of Stock available for grant under the Plan: (i)&nbsp;shares tendered by the Participant or withheld by the Company in payment of the purchase price of a Stock Option or, after March&nbsp;4, 2025, an option under the Previous Equity Plan, (ii)&nbsp;shares tendered by the Participant or withheld by the Company to satisfy any tax withholding obligation with respect to Options or Stock Appreciation Rights or, after March&nbsp;4, 2025, options or stock appreciation rights under the Previous Equity Plan, (iii)&nbsp;shares subject to a Stock Appreciation Right or, after March&nbsp;4, 2025, a share appreciation right under the Previous Equity Plan that are not issued in connection with its stock settlement on exercise thereof, and (iv)&nbsp;shares reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of Options or, after March&nbsp;4, options under the Prior Plan.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Director Limits</I>. The maximum number of shares of Stock subject to Awards granted during a single fiscal year to any non-employee Director, taken together with any cash fees paid during the fiscal year to the non-employee Director, in respect of the Director&rsquo;s service as a member of the Board during such year (including service as a member or chair of any committees of the Board), shall not exceed $750,000 in total value (calculating the value of any such Awards based on the grant date fair value of such Awards for financial reporting purposes). The independent members of the Board may make exceptions to this limit for a non-executive chair of the Board, provided that the non-employee Director receiving such additional compensation may not participate in the decision to award such compensation.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Character of Shares</I>. Any shares of Stock issued hereunder may consist, in whole or in part, of authorized and unissued shares, treasury shares or shares purchased in the open market or otherwise.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">(f)&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt"><I>Changes
in Stock</I>. Subject to Section&nbsp;3(g)&nbsp;hereof, if, as a result of any reorganization, recapitalization, reclassification,
stock dividend, stock split, reverse stock split, extraordinary cash dividend or other similar change in the Company&rsquo;s capital
stock, the outstanding shares of Stock are increased or decreased or are exchanged for a different number or kind of shares or other
securities of the Company, or additional shares or new or different shares or other securities of the Company or other non-cash
assets are distributed with respect to such shares of Stock or other securities, or, if, as a result of any merger or consolidation,
or sale of all or substantially all of the assets of the Company, the outstanding shares of Stock are converted into or exchanged
for a different number or kind of securities of the Company or any successor entity (or a parent or Subsidiary thereof), the
Administrator shall make an appropriate or proportionate adjustment in (i)&nbsp;the maximum number of shares reserved for issuance
under the Plan, (ii)&nbsp;the maximum number of shares of Stock that underlie Incentive Stock Options, (iii)&nbsp;the number and
kind of shares or other securities subject to any then outstanding Awards, (iv)&nbsp;the repurchase price, if any, per share of
Stock subject to each outstanding Restricted Stock Award, (v)&nbsp;the price for each share of Stock subject to any then outstanding
Stock Options and Stock Appreciation Rights, without changing the aggregate exercise price (i.e., the exercise price multiplied by
the number of Stock Options and Stock Appreciation Rights) as to which such Stock Options and Stock Appreciation Rights remain
exercisable, and (vi)&nbsp;and the terms and conditions of any outstanding Awards (including, without limitation, any applicable
performance targets or criteria with respect thereto). The adjustment by the Administrator shall be final, binding and conclusive.
No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Administrator in its
discretion may make a cash payment in lieu of fractional shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The Administrator shall
also adjust the number of shares of Stock subject to outstanding Awards and the exercise price and the terms of outstanding Awards in
a proportionate manner to take into consideration material changes in accounting practices or principles, extraordinary dividends, acquisitions
or dispositions of stock or property or any other similar event to avoid distortion in the operation of the Plan, provided that no such
adjustment shall be made in the case of a Stock Option or Stock Appreciation Right, without the consent of the grantee, if it would constitute
an adverse modification, extension or renewal of the Option within the meaning of Section&nbsp;424(h)&nbsp;of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in">(g)</TD><TD STYLE="text-align: justify"><I>Sale Event</I>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.25in"> <FONT STYLE="font-size: 10pt">(i)</FONT> <FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;If the Company is a party to a Sale Event, outstanding Awards shall be subject to the applicable agreement of merger, reorganization, or sale of assets (the &ldquo;<B><I><U>Sale Agreement</U></I></B>&rdquo;). Such agreement need not treat all Awards in an identical manner, and it will provide for one or more of the following with respect to each Award:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (A) &#8239;&#8239;The continuation of the Award by the Company (if the Company is the surviving corporation).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(B)</FONT> <FONT STYLE="font-size: 10pt">&#8239;&#8239;The assumption of the Award by the surviving corporation or its parent and, with respect to an Award that is subject to Section&nbsp;409A, in a manner that complies with Section&nbsp;424(a)&nbsp;of the Code (whether or not the Award is an Incentive Stock Option).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(C)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">The substitution by the surviving corporation or its parent of a new Award, and with respect to an Award that is subject to Section&nbsp;409A, in a manner that complies with Section&nbsp;424(a)&nbsp;of the Code (whether or not the Award is an Incentive Stock Option).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(D)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">Full exercisability of an Option, full vesting of the shares of Stock subject to an Option and/or full vesting of all other Awards, followed by the cancellation of the Option or Award. The full exercisability of an Option, full vesting of the shares of Stock subject to the Option and/or full vesting of all other Awards may be contingent on the closing of such Sale Event. The grantee will be able to exercise an Option during a period of not less than fifteen (15) full business days preceding the effective date of such Sale Event, unless a shorter period is required to permit a timely closing of such Sale Event and such shorter period still offers the grantee a reasonable opportunity to exercise an Option. Any exercise of an Option during such period may be contingent on the closing of such Sale Event. Notwithstanding the foregoing, if an Award&rsquo;s vesting or grant is based on the achievement of performance criteria then the Administrator may accelerate vesting or grant as to (1)&nbsp;the target number of shares of Stock that would be vested or awarded upon the achievement of such performance criteria, (2)&nbsp;the pro-rata amount (based on the number of days from the date of grant to the date of the Sale Event divided by the number of days in the applicable performance period) of the shares of Stock subject to the Award or grant of an Award, but only if the vesting or grant of the Award will not be determined based on actual results of the achievement of the performance criteria, (3)&nbsp;if set forth in the Award agreement, application of the performance criteria as of the date of the Sale Event or (iv)&nbsp;any other manner set forth in the applicable Award agreement.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(E)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">A payment to the grantee equal to the excess of (1)&nbsp;the Fair Market Value of the shares of Stock subject to the Award as of the effective date of such merger or consolidation over (2)&nbsp;the exercise price or purchase price of shares of Stock, as the case may be, subject to the Award in connection with the cancellation of the Award. Such payment will be made in the form of cash, cash equivalents, or securities of the surviving corporation or its parent with a Fair Market Value equal to the required amount. The successor corporation may provide substantially similar consideration to grantees as was provided to stockholders (after taking into account the existing provisions of the Awards). Subject to Section&nbsp;409A, such payment may be made in installments and may be deferred until the date or dates when the Award would have become exercisable or such shares of Stock would have vested. The amount of such payment initially will be calculated without regard to whether or not the Award is then exercisable or such shares of Stock are then vested. However, such payment may be subject to vesting based on the grantee&rsquo;s continuing service as an employee, consultant or director. In addition, any escrow, holdback, earn-out or similar provisions in the agreement of merger or consolidation may apply to such payment to the same extent and in the same manner as such provisions apply to the holders of shares of Stock. If the exercise price of the shares of Stock subject to an Option exceeds the Fair Market Value of such shares of Stock, then the Option may be cancelled without making a payment to the grantee. For purposes of this subsection, the Fair Market Value of any security will be determined without regard to any vesting conditions that may apply to such security.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">For the purposes of this subsection (g), the Award shall be considered assumed if, following the Sale Event, the Stock Option, Restricted Stock or other right confers the right to purchase or receive, for each share of Stock subject to the Award immediately prior to the Sale Event, the consideration (whether stock, cash, or other securities or property) received in the Sale Event by holders of Stock for each share of Stock held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Stock); provided, however, that if such consideration received in the Sale Event is not solely common stock of the successor corporation or its parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon the exercise of the Award, for each share of Stock subject to the Award, to be solely common stock of the successor corporation or its parent equal in fair market value to the per share consideration received by holders of Stock in the Sale Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.25in"> <FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">The Company shall have the discretion to provide in each Award agreement other terms and conditions that relate to (A)&nbsp;vesting of the Award in the event of a Sale Event, and (B)&nbsp;assumption of such Awards or issuance of comparable securities or new incentives in the event of a Sale Event. The aforementioned terms and conditions may vary in each Award agreement, and may be different from and have precedence over the provisions set forth in this Section&nbsp;3(g). The Company is not required to treat all Awards in an identical manner.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Substitute Awards</I>. The Administrator may grant &ldquo;<B><I><U>Substitute Awards</U></I></B>&rdquo; under the Plan in substitution for stock and stock-based awards held by employees, directors or other key persons of another corporation in connection with the merger or consolidation of the employing corporation with the Company or a Subsidiary or the acquisition by the Company or a Subsidiary of property or stock of the employing corporation. The Administrator may direct that the Substitute Awards be granted on such terms and conditions as the Administrator considers appropriate in the circumstances. Substitute Awards shall not reduce the shares authorized for grant under the Plan or the applicable limitations for grant to a grantee under Section&nbsp;3(d)&nbsp;or 10(d), nor shall shares subject to a Substitute Award again be available for Awards under the Plan to the extent of any forfeiture, expiration or cash settlement as provided in paragraph (b)&nbsp;above.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>No Dividends Payable with Respect to Unvested Awards</I>. Notwithstanding anything herein to the contrary, with respect to any Award under this Plan, no dividends (or dividend equivalents) shall be payable with respect to any shares of Stock underlying an Award until such Award (or the applicable part of the Award) has vested. Notwithstanding the foregoing, a grantee shall have the right to the accrual of dividends (or dividend equivalents) on the unvested portion of an Award that may be payable (either in (A)&nbsp;cash, (B)&nbsp;like-kind property as that subject to the applicable dividend, if not cash, (C)&nbsp;the form of a dividend equivalent increase in the number of shares of Stock issuable upon vesting, or (D)&nbsp;a combination of the foregoing) upon the vesting of the Award (or subject portion thereof).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(j)&#8239;&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Minimum Vesting Requirements</I>. Notwithstanding any other provision of the Plan to the contrary, Awards granted under the Plan (other than cash-based Awards) shall vest no earlier than the first anniversary of the date on which the Award is granted; provided, that the following Awards shall not be subject to the foregoing minimum vesting requirement: any (i)&nbsp;Substitute Awards granted in connection with a business acquisition, (ii)&nbsp;shares delivered in lieu of fully vested cash obligations, (iii)&nbsp;Awards to non-employee Directors that vest on the earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year&rsquo;s annual meeting, and (iv)&nbsp;any additional Awards the Committee may grant, up to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section&nbsp;3(a); and, provided, further, that the foregoing restriction does not apply to the Committee&rsquo;s discretion to provide for accelerated exercisability or vesting of any Award, including in cases of retirement, death, disability or a Sale Event, in the terms of the Award agreement or otherwise.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;4. <I>ELIGIBILITY</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Grantees under the Plan
will be such officers and other employees, directors and key persons (including consultants and prospective employees) of the Company
and its Subsidiaries as are selected from time to time by the Administrator in its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;5. <I>STOCK
OPTIONS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(a)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;Grant of Stock Options</I>. Any Stock Option granted under the Plan shall be in such form as the Administrator may from time to time approve. The grant of a Stock Option Award is contingent on the grantee executing an Award agreement in respect thereof as soon as reasonably practicable and in no event later than 45 days after the date of grant. Subject to any limitations within the Plan, the terms and conditions of each such agreement shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Stock Options granted
under the Plan may be either Incentive Stock Options or Non-Qualified Stock Options. Incentive Stock Options may be granted only to employees
of the Company or any &ldquo;subsidiary corporation&rdquo; within the meaning of Section&nbsp;424(f)&nbsp;of the Code. To the extent that
any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock Option. Stock Options granted pursuant
to this Section&nbsp;5 shall be subject to the following terms and conditions and shall contain such additional terms and conditions,
not inconsistent with the terms of the Plan, as the Administrator shall deem desirable. If the Administrator so determines, Stock Options
may be granted in lieu of cash compensation at the optionee&rsquo;s election, subject to such terms and conditions as the Administrator
may establish.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;Exercise Price</I>. The exercise price per share for the Stock covered by a Stock Option granted pursuant to this Section&nbsp;5 shall be determined by the Administrator at the time of grant but shall not be less than the Fair Market Value on the date of grant. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the option price of such Incentive Stock Option shall be not less than 110 percent of the Fair Market Value on the grant date.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Notwithstanding the
foregoing, a Stock Option may be granted with an exercise price lower than 100% of the Fair Market Value of the Stock if such Stock Option
is a Substitute Award and is granted in a manner consistent with the provisions of Section&nbsp;409A of the Code and, if applicable, Section&nbsp;424(a)&nbsp;of
the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">(c)<FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;Option Term</I>. The term of each Stock Option shall be fixed by the Administrator, but no Stock Option shall be exercisable more than ten years after the date the Stock Option is granted. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option shall be no more than five years from the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Notwithstanding the
foregoing, in the event that on the last business day of the term of a Stock Option (x)&nbsp;the exercise of the Stock Option is prohibited
by applicable law or (y)&nbsp;shares of Stock may not be purchased or sold by certain employees or directors of the Company due to the
 &ldquo;black-out period&rdquo; of a Company policy or a &ldquo;lock-up&rdquo; agreement undertaken in connection with an issuance of securities
by the Company, the Administrator may provide that the term of the Stock Option shall be extended but not beyond a period of thirty (30)
days following the end of the legal prohibition, black-out period or lock-up agreement and provided further that no extension will be
made if the exercise price of such Stock Option at the date the initial term would otherwise expire is above the Fair Market Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(d)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;Exercisability; Rights of a Stockholder</I>. Stock Options shall become exercisable after vesting at such time or times, whether or not in installments, as shall be determined by the Administrator at or after the grant date. The Administrator may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have the rights of a stockholder only as to shares of Stock acquired upon the exercise of a Stock Option and not as to unexercised Stock Options.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Method of Exercise</I>. Stock Options may be exercised in whole or in part, by giving written notice of exercise to the Company, specifying the number of shares of Stock to be purchased. Payment of the purchase price may be made by one or more of the following methods to the extent provided in the Option Award agreement or as approved by the Committee:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (i)&#8239;&#8239;&#8239;&#8239; In cash, by certified or bank check or other instrument acceptable to the Administrator;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(ii)</FONT> <FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;Through the delivery (or attestation to the ownership) of shares of Stock that have been purchased by the optionee on the open market or that are beneficially owned by the optionee and are not then subject to restrictions under any Company plan. Such surrendered shares shall be valued at Fair Market Value on the exercise date. To the extent required to avoid variable accounting treatment under applicable accounting rules, such surrendered shares of Stock shall have been owned by the optionee for at least six months;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">By the optionee delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price; provided that if optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Administrator shall prescribe as a condition of such payment procedure;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (iv) &#8239;&#8239;By reduction in the number of shares of Stock otherwise deliverable upon exercise of such Option with a Fair Market Value equal to (1)&nbsp;the aggregate option exercise price at the time of exercise, plus (2)&nbsp;the amount necessary to cover any tax withholding in respect of the exercise; or</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in"> (v)&#8239;&#8239; Any combination of the foregoing methods.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Payment instruments
will be received subject to collection. The transfer to the optionee on the records of the Company or of the transfer agent of the shares
of Stock to be purchased pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser
acting in his stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such shares and
the fulfillment of any other requirements contained in the Option Award agreement or applicable provisions of laws (including the satisfaction
of any withholding taxes that the Company is obligated to withhold with respect to the optionee). If an optionee chooses to pay the purchase
price by previously-owned shares of Stock through the attestation method, the number of shares of Stock transferred to the optionee upon
the exercise of the Stock Option shall be net of the number of shares of Stock attested to.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(f)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;&#8239;Annual Limit on Incentive Stock Options</I>. To the extent required for &ldquo;incentive stock option&rdquo; treatment under Section&nbsp;422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options granted under this Plan and any other plan of the Company (or its Parent, if any, or any &ldquo;subsidiary corporation&rdquo; within the meaning of Section&nbsp;424(f)&nbsp;of the Code) become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this limit, it shall constitute a Non-Qualified Stock Option.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;6. <I>STOCK
APPRECIATION RIGHTS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(a)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;Nature of Stock Appreciation Rights</I>. Stock Appreciation Rights entitle the recipient to receive shares of Stock having a value equal to the excess of the Fair Market Value of the Stock on the date of exercise over the exercise price of the Stock Appreciation Rights multiplied by the number of shares of Stock with respect to which the Stock Appreciation Rights shall have been exercised.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><FONT STYLE="font-size: 10pt">(b)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;Grant and Exercise of Stock Appreciation Rights</I>. Stock Appreciation Rights may be granted by the Administrator in tandem with, or independently of, any Stock Option granted pursuant to Section&nbsp;5 of the Plan. In the case of a Stock Appreciation Right granted in tandem with a Non-Qualified Stock Option, such Stock Appreciation Right may be granted either at or after the time of the grant of such Option. In the case of a Stock Appreciation Right granted in tandem with an Incentive Stock Option, such Stock Appreciation Right may be granted only at the time of the grant of the Stock Option.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">A Stock Appreciation
Right or applicable portion thereof granted in tandem with a Stock Option shall terminate and no longer be exercisable upon the termination
or exercise of the related Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Terms
and Conditions of Stock Appreciation Rights</I>. The grant of a Stock Appreciation Right is contingent on the grantee executing an
Award agreement in respect thereof as soon as reasonably practicable and in no event later than 45 days after the date of grant. The
terms and conditions of each such agreement shall be determined by the Administrator, and such terms and conditions may differ among
individual Awards and grantees, subject to any limitations within the Plan, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">The exercise price of a Stock Appreciation Right shall not be less than the Fair Market Value of a share of Stock on the date of grant (or more than the option exercise price per share, if the Stock Appreciation Right is granted in tandem with a Stock Option), provided that, a Stock Appreciation Right may be granted with an exercise price lower than 100% of the Fair Market Value of the Stock if such Stock Appreciation Right is a Substitute Award and is granted in a manner consistent with the provisions of Section&nbsp;409A of the Code and, if applicable, Section&nbsp;424(a)&nbsp;of the Code.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">Stock Appreciation Rights granted in tandem with Options shall be exercisable at such time or times and to the extent that the related Stock Options shall be exercisable.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (iii)&#8239;&#8239; Upon exercise of a Stock Appreciation Right, the applicable portion of any related Option shall be surrendered.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(iv)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt">No Stock Appreciation Right shall be exercisable more than ten years after the date the Stock Appreciation Right was granted, provided that, in the event that on the last business day of the term of a Stock Appreciation Right (x)&nbsp;the exercise of the Stock Appreciation Right is prohibited by applicable law or (y)&nbsp;shares of Stock may not be purchased or sold by certain employees or directors of the Company due to the &ldquo;black-out period&rdquo; of a Company policy or a &ldquo;lock-up&rdquo; agreement undertaken in connection with an issuance of securities by the Company, the Administrator may provide that the term of the Stock Appreciation Right shall be extended but not beyond a period of thirty (30) days following the end of the legal prohibition, black-out period or lock-up agreement and provided further that no extension will be made if the exercise price of such Stock Appreciation Right at the date the initial term would otherwise expire is above the Fair Market Value.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;7. <I>RESTRICTED
STOCK AWARDS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a)</FONT> <FONT STYLE="font-size: 10pt"><I>&#8239;&#8239;&#8239;Nature
of Restricted Stock Awards</I>. A Restricted Stock Award is an Award entitling the recipient to acquire, at such purchase price
(which may be equal or greater than the Stock&rsquo;s par value) as determined by the Administrator, shares of Stock subject to such
restrictions and conditions as the Administrator may determine at the time of grant (&ldquo;<B><I><U>Restricted
Stock</U></I></B>&rdquo;). Conditions may be based on continuing employment (or other service relationship) and/or achievement of
pre-established performance goals and objectives. The grant of a Restricted Stock Award is contingent on the grantee executing the
Restricted Stock Award agreement as soon as reasonably practicable and in no event later than 45 days after the date of grant. The
terms and conditions of each such agreement shall be determined by the Administrator, and such terms and conditions may differ among
individual Awards and grantees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Rights
as a Stockholder</I>. Upon execution of a written instrument setting forth the Award and payment of any applicable purchase price, a grantee
shall have the rights of a stockholder with respect to the voting of the Restricted Stock, subject to the limitations set forth in Section&nbsp;3(i)&nbsp;and
such other conditions contained in the written instrument evidencing the Restricted Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Unless the Administrator
shall otherwise determine, (i)&nbsp;uncertificated Restricted Stock shall be accompanied by a notation on the records of the Company or
the transfer agent to the effect that they are subject to forfeiture until such Restricted Stock is vested as provided in Section&nbsp;7(d)&nbsp;below,
and (ii)&nbsp;certificated Restricted Stock shall remain in the possession of the Company until such Restricted Stock is vested as provided
in Section&nbsp;7(d)&nbsp;below, and the grantee shall be required, as a condition of the grant, to deliver to the Company such instruments
of transfer as the Administrator may prescribe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;<I>Restrictions</I>.
Restricted Stock may not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of except as specifically provided
herein or in the Restricted Stock Award agreement. Except as may otherwise be provided by the Administrator either in the Award agreement
or, subject to Section&nbsp;15 below, in writing after the Award agreement is issued, if any, if a grantee&rsquo;s employment (or other
service relationship) with the Company and its Subsidiaries terminates for any reason, any Restricted Stock that has not vested at the
time of termination shall automatically and without any requirement of notice to such grantee from or other action by or on behalf of,
the Company be deemed to have been reacquired by the Company at its original purchase price from such grantee or such grantee&rsquo;s
legal representative simultaneously with such termination of employment (or other service relationship), and thereafter shall cease to
represent any ownership of the Company by the grantee or rights of the grantee as a stockholder. Following such deemed reacquisition
of unvested Restricted Stock that are represented by physical certificates, a grantee shall surrender such certificates to the Company
upon request without consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;<I>Vesting of Restricted Stock</I>. The Administrator at the time of grant shall specify the date or dates and/or the
attainment of pre-established performance goals, objectives, and other conditions on which the non-transferability of the shares of
Restricted Stock and the Company&rsquo;s right of repurchase or forfeiture shall lapse. Subsequent to such date or dates and/or the
attainment of such pre-established performance goals, objectives, and other conditions, the shares of Restricted Stock on which all
restrictions have lapsed shall no longer be Restricted Stock and shall be deemed &ldquo;vested.&rdquo; Except as may otherwise be
provided by the Administrator either in the Award agreement or, subject to Section&nbsp;15 below, in writing after the Award
agreement is issued, a grantee&rsquo;s rights in any shares of Restricted Stock that have not vested shall automatically terminate
upon the grantee&rsquo;s termination of employment (or other service relationship) with the Company and its Subsidiaries and such
shares of Restricted Stock shall be subject to the provisions of Section&nbsp;7(c)&nbsp;above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;8. <I>RESTRICTED
STOCK UNIT AWARDS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I>Nature
of Restricted Stock Unit Awards</I>. A Restricted Stock Unit Award is an Award of a right to receive an equivalent of one or more
shares of Stock, which value may be paid to the grantee in cash, shares of Stock or a combination of both as set forth in the
Restricted Stock Unit Award agreement and as the Committee determines in its sole discretion, and subject to restrictions and
conditions as the Administrator may determine at the time of grant. Restricted stock units do not constitute a share of Stock nor do
they represent any ownership interest in the Company. Notwithstanding the foregoing, any settlement of a Restricted Stock Unit Award
resulting in a fractional share of Stock shall settle such fractional share of Stock in cash. Conditions may be based on continuing
employment (or other service relationship) and/or achievement of pre-established performance goals and objectives. The grant of a
Restricted Stock Unit Award is contingent on the grantee executing a Restricted Stock Unit Award agreement as soon as reasonably
practicable and in no event later than 45 days after the date of grant. The terms and conditions of each such agreement shall be
determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;<I>Election
to Receive Restricted Stock Unit Awards in Lieu of Compensation</I>. The Administrator may, in its sole discretion, permit a grantee
to elect to receive a portion of future cash compensation otherwise due to such grantee in the form of a Restricted Stock Unit Award.
Any such election shall be made in writing and shall be delivered to the Company no later than the date specified by the Administrator
and in accordance with Section&nbsp;409A and such other rules&nbsp;and procedures established by the Administrator. The Administrator
shall have the sole right to determine whether and under what circumstances to permit such elections and to impose such limitations and
other terms and conditions thereon as the Administrator deems appropriate. Any such deferred compensation shall be converted to a fixed
number of restricted stock units based on the Fair Market Value of Stock on the date the compensation would otherwise have been paid
to the grantee but for the deferral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"> (c)&#8239;&#8239;&#8239; <I>Rights as a Stockholder</I>. During the deferral period, a grantee shall have no rights as a stockholder.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;<I>Termination</I>.
Except as may otherwise be provided by the Administrator either in the Award agreement or, subject to Section&nbsp;15 below, in writing
after the Award agreement is issued, a grantee&rsquo;s right in all restricted stock units under a Restricted Stock Unit Award that have
not vested shall automatically terminate upon the grantee&rsquo;s termination of employment (or cessation of service relationship) with
the Company and its Subsidiaries for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;9. <I>UNRESTRICTED STOCK
AWARDS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The Administrator may,
in its sole discretion, grant (or sell at par value or such higher purchase price determined by the Administrator) an Unrestricted Stock
Award to any grantee pursuant to which such grantee may receive shares of Stock free of any restrictions under the Plan. Unrestricted
Stock Awards may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;10. <I>RESERVED</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;11. <I>TRANSFERABILITY OF
AWARDS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I>Transferability</I>.
Except as provided in Section&nbsp;11(b)&nbsp;below, during a grantee&rsquo;s lifetime, his or her Awards shall be exercisable only by
the grantee, or by the grantee&rsquo;s legal representative or guardian in the event of the grantee&rsquo;s incapacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">No Awards shall be sold,
assigned, transferred or otherwise encumbered or disposed of by a grantee other than by will or by the laws of descent and distribution.
No Awards shall be subject, in whole or in part, to attachment, execution, or levy of any kind, and any purported transfer in violation
hereof shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;<I>Committee
Action</I>. Notwithstanding Section&nbsp;11(a), the Administrator, in its discretion, may provide either in the Award agreement regarding
a given Award or by subsequent written approval that the grantee (who is an employee or director) may transfer his or her Awards (other
than any Incentive Stock Options) without monetary consideration to his or her immediate family members, to trusts for the benefit of
such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing
with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;<I>Family
Member</I>. For purposes of Section&nbsp;11(b), &ldquo;family member&rdquo; shall mean a grantee&rsquo;s child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the grantee&rsquo;s household (other than a tenant
of the grantee), a trust in which these persons (or the grantee) have more than 50 percent of the beneficial interest, a foundation in
which these persons (or the grantee) control the management of assets, and any other entity in which these persons (or the grantee) own
more than 50 percent of the voting interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;</FONT>&#8239;<FONT STYLE="font-size: 10pt"><I>Designation
of Beneficiary</I>. Each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise
any Award or receive any payment under any Award payable on or after the grantee&rsquo;s death. Any such designation shall be on a form
provided for that purpose by the Administrator and shall not be effective until received by the Administrator. If no beneficiary has been
designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee&rsquo;s
estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;12. <I>TAX WITHHOLDING</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I>Payment
by Grantee</I>. Each grantee shall, no later than the date as of which the value of an Award or of any Stock or other amounts received
thereunder first becomes includable in the gross income of the grantee for Federal income tax purposes, pay to the Company, or make arrangements
satisfactory to the Administrator regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld
by the Company with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the right to
deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company&rsquo;s obligation to deliver evidence of
book entry (or stock certificates) to any grantee is subject to and conditioned on tax withholding obligations being satisfied by the
grantee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(b)&#8239;<I>Payment
in Stock</I>. Subject to approval by the Administrator, a grantee may elect to have the Company&rsquo;s minimum required tax withholding
obligation satisfied (or up to the maximum required tax withholding obligation satisfied if permitted by the Administrator in its sole
discretion), in whole or in part, by (i)&nbsp;authorizing the Company to withhold from shares of Stock to be issued pursuant to any Award
a number of shares with an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding
amount due, or (ii)&nbsp;transferring to the Company shares of Stock owned by the grantee with an aggregate Fair Market Value (as of
the date the withholding is effected) that would satisfy the withholding amount due; provided that if a grantee makes no such election,
then the grantee is deemed to authorize the Company to withhold shares of Stock as provided under subsection (i)&nbsp;of this Section&nbsp;12(b)&nbsp;in
the amount of the minimum required tax withholding obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>SECTION&nbsp;13.
<I>ADDITIONAL CONDITIONS APPLICABLE TO NONQUALIFIED DEFERRED COMPENSATION UNDER SECTION&nbsp;409A</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">If any Stock Option
or Stock Appreciation Right under the Plan is unintentionally granted with an exercise price of less than 100 percent of the Fair Market
Value of the Stock on the date of grant, or such grant is materially modified and deemed a new grant at a time when the Fair Market Value
of the Stock exceeds the exercise price, or any other Award is otherwise determined to constitute &ldquo;nonqualified deferred compensation&rdquo;
within the meaning of Section&nbsp;409A (a &ldquo;<B><I><U>409A Award</U></I></B>&rdquo;), the following additional conditions shall apply
and shall supersede any contrary provisions of this Plan or the terms of any agreement relating to such 409A Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I>Exercise
and Distribution</I>. Except as provided in Section&nbsp;13(b)&nbsp;hereof, no 409A Award shall be exercisable or distributable earlier
than upon one of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (i)&#8239;&#8239;&#8239;&#8239; <I>Specified Time</I>. A specified time or a fixed schedule set forth in the written instrument evidencing the 409A Award.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Separation from Service</I>. Separation from service (within the meaning of Section&nbsp;409A) by the 409A Award grantee; provided, however, that if the 409A Award grantee is a &ldquo;specified employee&rdquo; (as defined in Section&nbsp;409A(a)(2)(B)(1)&nbsp;of the Code and regulations promulgated thereunder), exercise or distribution under this Section&nbsp;13(a)(ii)&nbsp;may not be made before the date that is six months after the date of separation from service.</FONT></P>



<P STYLE="margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (iii) &#8239;&#8239;<I>Death</I>. The date of death of the 409A Award grantee.</P>



<P STYLE="margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> (iv)&#8239;&#8239; <I>Disability</I>. The date the 409A Award grantee becomes Disabled (within the meaning of Section&nbsp;13(c)(ii)&nbsp;hereof).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(v)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Unforeseeable Emergency</I>. The occurrence of an Unforeseeable Emergency (within the meaning of Section&nbsp;13(c)(iii)&nbsp;hereof), but only if the net value (after payment of the exercise price) of the number of shares of Stock that become issuable does not exceed the amounts necessary to satisfy such emergency plus amounts necessary to pay taxes reasonably anticipated as a result of the exercise, after taking into account the extent to which the emergency is or may be relieved through reimbursement or compensation by insurance or otherwise or by liquidation of the grantee&rsquo;s other assets (to the extent such liquidation would not itself cause severe financial hardship).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(vi)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Change in Control Event</I>. The occurrence of a Change in Control Event (within the meaning of Section&nbsp;13(c)(i)&nbsp;hereof), including the Company&rsquo;s discretionary exercise of the right to accelerate vesting of such grant upon a Change in Control Event or to terminate the Plan or any 409A Award granted hereunder within 12 months of the Change in Control Event; provided that the rules&nbsp;related to a Plan termination upon a Change in Control Event shall also apply.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;</FONT>&#8239;<FONT STYLE="font-size: 10pt"><I>No
Acceleration</I>. The payment, settlement or disposition of a 409A Award may not be accelerated prior to the time specified in Section&nbsp;13(a)&nbsp;hereof,
except in the case of one of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Domestic Relations Order</I>. The 409A Award may permit the acceleration of the exercise or distribution time or schedule to an individual other than the grantee as may be necessary to comply with the terms of a domestic relations order (as defined in Section&nbsp;414(p)(1)(B)&nbsp;of the Code).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Conflicts of Interest</I>. The 409A Award may permit the acceleration of the exercise or distribution time or schedule as may be necessary to comply with the terms of a certificate of divestiture (as defined in Section&nbsp;1043(b)(2)&nbsp;of the Code).</FONT></P>

<P STYLE="margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>Change in Control Event</I>. The Administrator may exercise the discretionary right to accelerate the vesting of such 409A Award upon a Change in Control Event or to terminate the Plan or any 409A Award granted thereunder within 12 months of the Change in Control Event and cancel the 409A Award for compensation.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;<I>Definitions</I>.
Solely for purposes of this Section&nbsp;13 and not for other purposes of the Plan, the following terms shall be defined as set forth
below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0 0 0 0.5in; text-align: justify"> <FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>&ldquo;<B><U>Change in Control Event</U></B>&rdquo; </I>means the occurrence of a change in the ownership of the Company, a change in effective control of the Company, or a change in the ownership of a substantial portion of the assets of the Company (as defined in Section&nbsp;1.409A-3(i)(5)&nbsp;of the regulations promulgated under Section&nbsp;409A).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>&ldquo;<B><U>Disabled</U></B>&rdquo; </I>means a grantee who (i)&nbsp;is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, (ii)&nbsp;is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of the Company or its Subsidiaries, or (iii)&nbsp;is determined to be totally disabled by the Social Security Administration.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0 0 0 0.5in"> <FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;</FONT> <FONT STYLE="font-size: 10pt"><I>&ldquo;<B><U>Unforeseeable Emergency</U></B>&rdquo; </I>means a severe financial hardship to the grantee resulting from an illness or accident of the grantee, the grantee&rsquo;s spouse, or a dependent (as defined in Section&nbsp;152(a)&nbsp;of the Code) of the grantee, loss of the grantee&rsquo;s property due to casualty, or similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the grantee.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;<I>Interpretation
of Plan to Comply with Section&nbsp;409A</I>. The Plan is intended to comply with Section&nbsp;409A of the Code to the extent subject
thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith.
Any payments described in the Plan that are due within the &ldquo;short-term deferral period&rdquo; as defined in Section&nbsp;409A of
the Code shall not be treated as deferred compensation unless applicable law requires otherwise. Notwithstanding anything to the contrary
in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section&nbsp;409A of the Code, amounts that
would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six-month period immediately
following the grantee&rsquo;s termination of service shall instead be paid on the first payroll date after the six-month anniversary
of the grantee&rsquo;s separation from service (or his or her death, if earlier). Notwithstanding the foregoing, neither the Company
nor the Administrator shall have any obligation to take any action to prevent the assessment of any excise tax or penalty on any grantee
under Section&nbsp;409A of the Code and neither the Company nor the Administrator will have any liability to any grantee for such tax
or penalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;14. <I>TRANSFER, LEAVE OF
ABSENCE,&nbsp;ETC.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">For purposes of the
Plan, the following events shall not be deemed a termination of employment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"> (a) &#8239;&#8239;&#8239;a transfer to the employment of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;an approved leave of absence for military
service or sickness, or for any other purpose approved by the Company, if the employee&rsquo;s right to re-employment is guaranteed either
by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise
so provides in writing, or</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify"> (c)&#8239;&#8239;&#8239; any other transfer that the Committee in its sole discretion determines is not a termination of employment.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Subject to Section&nbsp;14(b)&nbsp;and
(c)&nbsp;above, if the employee&rsquo;s employer ceases to be the Company or a Subsidiary, the employee shall be deemed to have terminated
employment for purposes of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;15. <I>AMENDMENTS AND TERMINATION</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The Board may, at any
time, amend or discontinue the Plan and the Administrator may, at any time, amend or cancel any outstanding Award for the purpose of satisfying
changes in law or for any other lawful purpose, but, unless otherwise required by law, no such action shall adversely affect in any material
respect rights under any outstanding Award without the grantee&rsquo;s consent. Except in connection with a Sale Event involving the Company
or a change in Stock (such as a stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation,
split-up, spin-off, combination, or exchange of shares) as provided in Section&nbsp;3(f)&nbsp;or 3(g), unless there is stockholder approval,
the terms of outstanding awards may not be amended to reduce the exercise price of outstanding Options or Stock Appreciation Rights, and
outstanding Options or Stock Appreciation Rights that are underwater (i.e., the exercise price per share exceeds the Fair Market Value
per share) may not be cancelled in exchange for cash, other awards or Options or Stock Appreciation Rights with an exercise price that
is less than the exercise price of the original Options or Stock Appreciation Rights. Any material Plan amendments (other than amendments
that curtail the scope of the Plan), including any Plan amendments that (i)&nbsp;increase the number of shares reserved for issuance under
the Plan (except pursuant to Section&nbsp;3(f)&nbsp;of the Plan), (ii)&nbsp;expand the type of Awards available under, materially expand
the eligibility to participate in, or materially extend the term of, the Plan, or (iii)&nbsp;materially change the method of determining
Fair Market Value, shall be subject to approval by the Company stockholders entitled to vote at a meeting of stockholders. In addition,
to the extent determined by the Administrator to be required by the Code to ensure that Incentive Stock Options granted under the Plan
are qualified under Section&nbsp;422 of the Code, Plan amendments shall not be subject to approval by the Company stockholders entitled
to vote at a meeting of stockholders or to approval of any grantee of such Incentive Stock Options. Nothing in this Section&nbsp;15 shall
limit the Administrator&rsquo;s authority to take any action permitted pursuant to Section&nbsp;3(g).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;16. <I>STATUS OF PLAN</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">With respect to the
portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a grantee, a grantee
shall have no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise expressly determine
in connection with any Award or Awards. In its sole discretion, the Administrator may authorize the creation of trusts or other arrangements
to meet the Company&rsquo;s obligations to deliver Stock or make payments with respect to Awards hereunder, provided that the existence
of such trusts or other arrangements is consistent with the foregoing sentence.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;17. <I>GENERAL PROVISIONS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I>No
Distribution; Compliance with Legal Requirements</I>. The Administrator may require each person acquiring Stock pursuant to an Award
to represent to and agree with the Company in writing that such person is acquiring the shares without a view to distribution thereof.
No shares of Stock shall be issued pursuant to an Award until all applicable securities law and other legal and stock exchange or similar
requirements have been satisfied. The Administrator may require the placing of such stop-orders and restrictive legends on certificates
for Stock and Awards as it deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;<I>Delivery
of Stock</I>. Upon exercise of a right granted under this Plan, the Company shall issue the applicable shares of Stock or pay any amounts
due within a reasonable period of time thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Other
Compensation Arrangements; No Employment Rights</I>. Nothing contained in this Plan shall prevent the Board from adopting other or additional
compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases.
The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued employment with the Company or
any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;<I>Incorporation
of Company Policy Restrictions</I>. Option exercises and grant or settlement of Awards under the Plan shall be subject to the following:
(i)&nbsp;the Company&rsquo;s insider trading policy and procedures, as in effect from time to time, (ii)&nbsp;the policies that the Company
adopts prior to or after the grant of any Award under this Plan, including in connection with applicable Federal, state or local law,
government regulations or stock exchange listing requirements, such as the Sarbanes-Oxley Act or the Dodd-Frank Act. The action permitted
to be taken under this Section&nbsp;17(d)&nbsp;is in addition to, and not in lieu of, any and all other rights of the Administrator or
the Company under applicable law and shall apply notwithstanding anything to the contrary in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Clawback;
Forfeiture Events</I>. The Committee may specify in an Award agreement that the grantee&rsquo;s rights, payments and benefits with respect
to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain events, in addition to
applicable vesting conditions of an Award. Such events may include, without limitation, breach of non-competition, non-solicitation, confidentiality,
or other restrictive covenants that are contained in the Award agreement or otherwise applicable to the grantee, or other conduct by the
grantee that is detrimental to the business or reputation of the Company or its affiliates. Awards may also be subject to recovery under
any law, government regulation, stock exchange listing requirement or Company policy adopted pursuant to such laws, including without
limitation, the federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;<I>No
Fractional Shares</I>. No fractional shares of Stock shall be issued or delivered pursuant to the Plan. The Committee shall determine
whether cash, additional Awards or other securities or property shall be issued or paid in lieu of fractional shares of Stock or whether
any fractional shares should be rounded, forfeited or otherwise eliminated. In the case of an exercise of Stock Appreciation Rights,
the Company shall aggregate all Stock Appreciation Rights exercised simultaneously by the grantee in determining any fractional share
of Stock that would remain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;<I>Section&nbsp;16</I>.
It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable requirements of
Rule&nbsp;16b-3 as promulgated under Section&nbsp;16 of the Exchange Act so that grantees subject to Section&nbsp;16 of the Exchange
Act will be entitled to the benefit of Rule&nbsp;16b-3, or any other rule&nbsp;promulgated under Section&nbsp;16 of the Exchange Act,
and will not be subject to short-swing liability thereunder. Accordingly, if the operation of any provision of the Plan would conflict
with the intent expressed in this Section&nbsp;17(g), such provision to the extent possible shall be interpreted and/or deemed amended
so as to avoid such conflict unless the Administrator expressly deems otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;<I>Non-Uniform
Treatment</I>. The Committee&rsquo;s determinations under the Plan need not be uniform and may be made by it selectively among persons
who are eligible to receive, or actually receive, Awards. Without limiting the generality of the foregoing, the Committee shall be entitled
to make non-uniform and selective determinations, amendments and adjustments, and to enter into non-uniform and selective Award agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;18. <I>EFFECTIVE DATE OF
PLAN</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">This Plan shall become
effective on the date of approval by the holders of a majority of the votes cast at a meeting of stockholders at which a quorum is present.
No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the effective date of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>SECTION&nbsp;19. <I>GOVERNING LAW</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">This Plan and all Awards
and actions taken thereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware, applied without
regard to conflict of law principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>DATE AMN HEALTHCARE 2025 EQUITY PLAN APPROVED
BY BOARD OF DIRECTORS</B>: March&nbsp;13, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>amn-20250502.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWamI6bOdzZR+GYkxtmB8bel6ryUibTBloCh2Qf3GkSEC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:AMN="http://amnhealthcare.com/20250502" elementFormDefault="qualified" targetNamespace="http://amnhealthcare.com/20250502">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://amnhealthcare.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="amn-20250502_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="amn-20250502_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>amn-20250502_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>amn-20250502_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://amnhealthcare.com/role/Cover" xlink:href="amn-20250502.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://amnhealthcare.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  02,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMN HEALTHCARE SERVICES,&#160;INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001142750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1500476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2999 Olympus
Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">871-8519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !A I5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( !A I5HGY;SX[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    "  80*5:1L=-2)4   #-    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !A I5HGY;SX
M[@   "L"   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( !A I5J97)PC$ 8  )PG   3              "  > !  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ &$"E6E]P5&1G!   )Q$
M !@              ("!(0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( !A I5J?H!OPL0(  .(,   -              "  ;X,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ &$"E6I>*NQS     $P(   L
M         ( !F@\  %]R96QS+RYR96QS4$L! A0#%     @ &$"E6JK$(A8S
M 0  (@(   \              ( !@Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( !A I5HD'INBK0   /@!   :              "  >,1  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( !A I5IED'F2&0$
M ,\#   3              "  <@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  !(4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2513592d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amnhealthcare.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>amn-20250502.xsd</File>
    <File>amn-20250502_lab.xml</File>
    <File>amn-20250502_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2513592d1_8k.htm">tm2513592d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2513592d1_8k.htm": {
   "nsprefix": "AMN",
   "nsuri": "http://amnhealthcare.com/20250502",
   "dts": {
    "schema": {
     "local": [
      "amn-20250502.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "amn-20250502_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amn-20250502_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2513592d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://amnhealthcare.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2513592d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2513592d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://amnhealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-25-044363-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-044363-xbrl.zip
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M^$" GZJ!Q-^B7GAX/"(A'\\IYRZ5(P*TEY?I@=A_Q\3N]_D*P-\\N_.[/;7
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M7>H" ;S3,4L\FE2Z2P\H#%:0PV!RA6D68V@BKV&^0NH*ZS[<8MAP7M1F5F3
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M<O+"1>;%3Y\^Q?\+=?HDS^P2Q =)?2V%8)&ZTQ)0.#W91' =9]3(URG9;A%
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MY&',OTUEH(IJ<KD-WSVFAF'(ZF4>5^I_:2O)M*#I4U8/:+WO+03H^QT$Z%M
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M^'#09C*GMC$KT\+"& -.I4J8G]FM"C*+.K5TW%7Z>9^L!6U1&/(GA#4[+FE
MI+:HC#6(CQ<1(94JF9J&-X)<YS)1>!>0AYE4I!KTF1U,DN=815C1FO1(]!Z,
M&M5[.6Q69*I1,U_!U.YM;/:2"P688P<A];-04'OQ9(>SG*PEKQ:RIOI41'1/
M]$=P5*^4(%42ZB#N5F"JSQR7ANV#T07:02OBX;"ED</!%ON) P_=UXC";T$L
M?.8E0%)(+\U64>9,%QK  *E00D;XZ*I^OF;5_/<>'VH<O3L^_/V8^5!?GQ^?
MOCF.^8?'%V^>[(IW^HMWVA1@-5;XAJ)I8H]YNL44PO32L?]TS^>\)ZUG VE@
M,D=!TRBQE():P5D2^I;WQ]:^]?[('Z0/W5\16,?^)C8_0@2%<RV)$])3+Q^
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M^@\#"__=Z_='_WJ%__CUXK=WK_Y_4$L! A0#%     @ &$"E6OYD)X8M P
M[@L  !               ( !     &%M;BTR,#(U,#4P,BYX<V102P$"% ,4
M    "  80*5:)"[-C/P*  !_A@  %               @ %; P  86UN+3(P
M,C4P-3 R7VQA8BYX;6Q02P$"% ,4    "  80*5:$E'E75D'  #=5P  %
M            @ &)#@  86UN+3(P,C4P-3 R7W!R92YX;6Q02P$"% ,4
M"  80*5:,/P$B_X7   =PP  $@              @ $4%@  =&TR-3$S-3DR
M9#%?.&LN:'1M4$L! A0#%     @ &$"E6A4\T-F[6@  E1<" !8
M     ( !0BX  '1M,C4Q,S4Y,F0Q7V5X,3 M,2YH=&U02P4&      4 !0!&
) 0  ,8D

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm2513592d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amn-20250502.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2025-05-02</startDate>
            <endDate>2025-05-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-02" id="Fact000004">0001142750</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-02" id="Fact000010">2025-05-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-02" id="Fact000011">AMN HEALTHCARE SERVICES,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-02" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-02" id="Fact000013">001-16753</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-02" id="Fact000014">06-1500476</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-02" id="Fact000015">2999 Olympus Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-05-02" id="Fact000016">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-02" id="Fact000017">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-02" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-02" id="Fact000019">75019</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-02" id="Fact000020">866</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-02" id="Fact000021">871-8519</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-02" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-02" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-02" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-02" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-05-02" id="Fact000026">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-02" id="Fact000027">AMN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-02" id="Fact000028">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-02" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
